tiprankstipranks
Artiva Biotherapeutics, Inc. (ARTV)
NASDAQ:ARTV
US Market

Artiva Biotherapeutics, Inc. (ARTV) Income Statement

Compare
17 Followers

Artiva Biotherapeutics, Inc. Income Statement

Last quarter (Q3 2024), Artiva Biotherapeutics, Inc.'s total revenue was $0.00, a decrease of ― from previous quarter. In Q3, Artiva Biotherapeutics, Inc.'s net income was $-17.47M. See Artiva Biotherapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 33.49M$ 4.93M$ 2.00M$ 0.00
Gross Profit
$ 33.49M$ 4.93M$ 2.00M$ 0.00
Operating Expenses
$ 64.16M$ 64.76M$ 55.27M$ 18.27M
Depreciation and Amortization
$ 2.27M$ 1.16M$ 248.00K$ 73.00K
EBITDA
$ -28.41M$ -58.67M$ -71.58M$ -17.72M
Operating Income
$ -30.67M$ -59.83M$ -53.27M$ -18.27M
Other Income/Expenses
$ 3.05M$ 1.49M$ -18.55M$ 280.00K
Pretax Income
$ -27.62M$ -58.34M$ -71.83M$ -17.99M
Net Income
$ -27.70M$ -58.39M$ -71.83M$ -17.99M
Per Share Metrics
$ ―$ ―$ ―$ ―
Basic EPS
$ -2.96$ -3.32$ -4.08$ -1.02
Diluted EPS
$ -2.96$ -3.32$ -4.08$ -1.02
Weighted Average Shares Outstanding
9.35M 17.58M 17.58M 17.58M
Weighted Average Shares Outstanding (Diluted)
9.35M 17.58M 17.58M 17.58M
Currency in USD

Artiva Biotherapeutics, Inc. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis